Cargando…
Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples o...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649689/ https://www.ncbi.nlm.nih.gov/pubmed/23690656 http://dx.doi.org/10.1155/2013/183653 |
_version_ | 1782269018048036864 |
---|---|
author | Ally, Mahmood M. T. M. Hodkinson, Bridget Meyer, Pieter W. A. Musenge, Eustasius Tikly, Mohammed Anderson, Ronald |
author_facet | Ally, Mahmood M. T. M. Hodkinson, Bridget Meyer, Pieter W. A. Musenge, Eustasius Tikly, Mohammed Anderson, Ronald |
author_sort | Ally, Mahmood M. T. M. |
collection | PubMed |
description | Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples of 128 disease-modifying, drug-naïve patients and analysed in relation to shared epitope genotype, a range of circulating chemokines/cytokines, acute phase reactants, autoantibodies, cartilage oligomeric protein (COMP), and the simplified disease activity index (SDAI). MMP-3 was elevated >1.86 ng/ml in 56.25% of patients (P < 0.0001), correlated with several biomarkers, notably IL-8, IL-6, IFN γ, VEGF and COMP (r values = 0.22–0.33, P < 0.014–0.0001) and with CRP and SAA levels (r = 0.40 and 0.41, resp., P < 0.0000) and SDAI (r = 0.29, P < 0.0001), but not with erosions or nodulosis. However, the correlations of CRP and SAA with SDAI were stronger (respective values of 0.63 and 0.54, P < 0.001 for both). COMP correlated with smoking, RF, and MMP-3. MMP-3 is significantly associated with disease activity, inflammatory mediators and cartilage breakdown, making it a potential biomarker of disease severity, but seemingly less useful than CRP and SAA as a biomarker of disease activity in early RA. |
format | Online Article Text |
id | pubmed-3649689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36496892013-05-20 Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis Ally, Mahmood M. T. M. Hodkinson, Bridget Meyer, Pieter W. A. Musenge, Eustasius Tikly, Mohammed Anderson, Ronald Mediators Inflamm Clinical Study Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples of 128 disease-modifying, drug-naïve patients and analysed in relation to shared epitope genotype, a range of circulating chemokines/cytokines, acute phase reactants, autoantibodies, cartilage oligomeric protein (COMP), and the simplified disease activity index (SDAI). MMP-3 was elevated >1.86 ng/ml in 56.25% of patients (P < 0.0001), correlated with several biomarkers, notably IL-8, IL-6, IFN γ, VEGF and COMP (r values = 0.22–0.33, P < 0.014–0.0001) and with CRP and SAA levels (r = 0.40 and 0.41, resp., P < 0.0000) and SDAI (r = 0.29, P < 0.0001), but not with erosions or nodulosis. However, the correlations of CRP and SAA with SDAI were stronger (respective values of 0.63 and 0.54, P < 0.001 for both). COMP correlated with smoking, RF, and MMP-3. MMP-3 is significantly associated with disease activity, inflammatory mediators and cartilage breakdown, making it a potential biomarker of disease severity, but seemingly less useful than CRP and SAA as a biomarker of disease activity in early RA. Hindawi Publishing Corporation 2013 2013-04-07 /pmc/articles/PMC3649689/ /pubmed/23690656 http://dx.doi.org/10.1155/2013/183653 Text en Copyright © 2013 Mahmood M. T. M. Ally et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Ally, Mahmood M. T. M. Hodkinson, Bridget Meyer, Pieter W. A. Musenge, Eustasius Tikly, Mohammed Anderson, Ronald Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_full | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_fullStr | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_full_unstemmed | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_short | Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis |
title_sort | serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649689/ https://www.ncbi.nlm.nih.gov/pubmed/23690656 http://dx.doi.org/10.1155/2013/183653 |
work_keys_str_mv | AT allymahmoodmtm serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT hodkinsonbridget serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT meyerpieterwa serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT musengeeustasius serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT tiklymohammed serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis AT andersonronald serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis |